Endoscopic diagnosis of cholangiocarcinoma: From endoscopic retrograde cholangiography to bile proteomics

Voigtländer, Torsten; Lankisch, Tim O.

doi:10.1016/j.bpg.2015.02.005

Cited by 24 publications

(18 citation statements)

References 61 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…16 These could increase accuracy with different diagnostic tools; cholangioscopy, endoscopic and intraductal ultrasound, confocal laser endomicroscopy, bile and urine proteomic analyses. Cholangioscopy allows a direct visualization and targeted biopsies with sensitivity of 60.1%, 17 and the sensitivity of intraductal ultrasound is about 88%.…”

Section: Discussionmentioning

confidence: 99%

A Case of Adenomyomatous Hyperplasia of the Distal Common Bile Duct Mimicking Malignant Stricture

Choi

Lee

Kim

et al. 2016

Korean J Gastroenterol

View full text Add to dashboard Cite

Adenomyomatous hyperplasia is a reactive malformation or non-neoplastic tumor-like lesion frequently observed in the gallbladder, stomach, duodenum and jejunum, but rare in the extrahepatic bile duct. A 42-year-old man with epigastric discomfort had a stricture in the common bile duct on initial CT scans. Initially, it was regarded as a malignant lesion with some evidence, but histopathologic examinations of multiple biopsies obtained by multiple sessions of endoscopic retrograde cholangiopancreatography showed no evidence of malignancy. The patient had undergone the pylorus preserving pancreaticoduodenectomy because of the possibility of malignancy; however, the final diagnosis was adenomyomatous hyperplasia. It is important to distinguish a malignancy from benign biliary stricture with endoscopic biopsies. Surgery for suspected biliary malignancy often reveals benign lesions. Therefore, a correct diagnosis is important before deciding upon treatment of bile duct stricture. In conclusion, in younger patients with bile duct stricture where there is no evidence of histologic malignancy despite multiple biopsies, the possibility of benign disease such as adenomyomatous hyperplasia should be considered, to avoid unnecessary radical surgery. (Korean J Gastroenterol 2016;67:332-336)

show abstract

Section: Discussionmentioning

confidence: 99%

A Case of Adenomyomatous Hyperplasia of the Distal Common Bile Duct Mimicking Malignant Stricture

Choi

Lee

Kim

et al. 2016

Korean J Gastroenterol

View full text Add to dashboard Cite

show abstract

“…8,9 However, a sensitivity of 72% in the case when the presence of CC is defined as a positive test result in both the BPA and UPA test is still not markedly higher than the reported sensitivity of imaging techniques and endoscopic interventions. [11][12][13][14][15][16][17] This implicates the need for a complimentary test with the trait of a high sensitivity.…”

Section: Discussionmentioning

confidence: 99%

A combined bile and urine proteomic test for cholangiocarcinoma diagnosis in patients with biliary strictures of unknown origin

Voigtländer¹,

Metzger²,

Jäger³

et al. 2017

Journal of Hepatology

View full text Add to dashboard Cite

“…In contrast to non-invasive imaging, ERC allows for the direct visualization of the extrahepatic bile ducts by cholangioscopy [79,80] and for direct confirmation of suspected CCA by cytology or histology [81]. Direct evidence for dysplastic bile duct cells or malignant CCA cells can be obtained from brush cytology [82,83].…”

Section: Endoscopic Surveillancementioning

confidence: 99%

Surveillance in cholangiocellular carcinoma

Wirth

Vogel

2016

Best Practice & Research Clinical Gastroenterology

View full text Add to dashboard Cite

Endoscopic diagnosis of cholangiocarcinoma: From endoscopic retrograde cholangiography to bile proteomics

Cited by 24 publications

References 61 publications

A Case of Adenomyomatous Hyperplasia of the Distal Common Bile Duct Mimicking Malignant Stricture

A Case of Adenomyomatous Hyperplasia of the Distal Common Bile Duct Mimicking Malignant Stricture

A combined bile and urine proteomic test for cholangiocarcinoma diagnosis in patients with biliary strictures of unknown origin

Surveillance in cholangiocellular carcinoma

Contact Info

Product

Resources

About